GMED Globus Medical, Inc.

68.60USD-2.74%Mkt Cap: 9.09B USDP/E: 16.90

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion …

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap9.09B USD
Enterprise Value8.93B USD
Revenue (TTM)3.14B USD
Gross Profit1.98B USD
Net Income (TTM)537.87M USD
Revenue/Share23.30 USD
Last Price68.60 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees6.0K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)16.90
P/E (Forward)12.85
PEG2.70
EV/EBITDA8.71
EV/Revenue2.85
P/S2.89
P/B1.90
EPS (TTM)4.06 USD
EPS (Forward)5.34 USD
52W Range
68.271% of range101.40
52W High101.40 USD
52W Low68.27 USD
Profitability
Gross Margin67.41%
Oper. Margin23.76%
EBITDA Margin32.66%
Profit Margin18.30%
ROE11.76%
ROA10.14%
ROIC11.55%
ROCE11.18%
Growth
Revenue Growth-0.70%
Earnings Growth18.20%
Cash Flow & Leverage
Operating CF753.45M USD
CapEx (TTM)174.43M USD
FCF Margin16.24%
FCF Yield5.61%
Net Debt-409.25M USD
Net Debt/EBITDA-0.40
Net Debt/FCF-0.80
Balance Sheet
Debt/Equity0.03
Current Ratio4.30
Quick Ratio2.44
Book Value/Sh36.15 USD
Cash/Share3.91 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.9 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)93.43 USD
Upside (mean)+36.2%
Target Range75.00 USD – 110.00 USD
75.00+36.2% to mean110.00
# Analysts14
Ownership
Shares Out.110.04M
Float109.13M
Insiders0.75%
Institutions113.38%
Short Interest
Short Ratio7.1d
Short % Float8.64%
Short % Out.7.13%
Shares Short9.46M
Short (prev mo.)8.44M
Technical
SMA 5076.40 (-10.2%)
SMA 20082.60 (-17.0%)
Beta0.95
S&P 52W Chg12.08%
Avg Vol (30d)1.77M
Avg Vol (10d)2.92M
Technical Indicators
RSI (14)37.4
MACD-2.1969
MACD Signal-1.0958
MACD Hist.-1.1011
BB Upper87.44 USD
BB Middle76.81 USD
BB Lower66.17 USD
BB Width27.70%
ATR (14)3.117 USD
Vol Ratio (20d)0.64x

About Globus Medical (NYSE: GMED)

›

Globus Medical (NYSE: GMED) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 6,000 employees.

The shares were at 68.60 USD on 19 November 2026, down 18.8% over 52 weeks. Its 52-week range is 68.27 USD to 101.40 USD, and it trades at the bottom of that range.

At a market capitalisation of 9.09B USD, it trades at 16.9 times trailing earnings and 12.9 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.6, a discount of 34% for GMED.

Globus Medical reports return on equity of 11.8%, an operating margin of 23.8% and revenue down 0.7% year over year.

It holds more cash than debt, a net cash position of 409.25M USD. Its Piotroski F-score is 9 out of 9, a strong reading of its financial health. 14 analysts cover the stock, with an average rating of Buy; their mean price target of 93.43 USD is 36.2% above the current price. The next earnings report is expected on 25 February 2027.